Oncology & Cancer

Sister cells uncover pre-existing resistant states in cancer

In many cancers, such as ovarian cancer, each round of chemotherapy kills the majority of cancer cells, while a small population of them survives through treatment. These cells are typically more resistant for the next cycle ...

Oncology & Cancer

Clues to cancer drug's deadly side effects could make it safer

For some leukemia patients, the only potential chemotherapy option is a drug that also carries a high risk of heart failure. This means that some patients who recover from their cancer will end up dying of heart disease brought ...

Medications

Review paper compares two leading pancreatic cancer drugs

An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...

Oncology & Cancer

Doctors may not be giving young cancer patients what they need

The rate of cancer deaths in the U.S. has steadily declined for several decades. But there's a caveat: We've recently seen a small but worrisome increase in the rate of certain cancers—particularly colon cancers—among ...

page 10 from 40